Skip to main content
×
Home
    • Aa
    • Aa

Cross-design Synthesis: A New Form of Meta-analysis for Combining Results from Randomized Clinical Trials and Medical-practice Databases

  • Judith Droitcour (a1), George Silberman (a1) and Eleanor Chelimsky (a1)
Abstract
Abstract

Cross-design synthesis is a new (and still evolving) strategy for providing quantitative results that capture the strengths and minimize the weaknesses of different kinds of research. The strategy, which is being developed to answer questions about the effects of treatment in medical practice, includes (a) identifying complementary research designs and studies conducted according to those designs; (b) completing an in-depth assessment of each study with respect to the chief potential bias(es) that are associated with its design; (c) making “secondary adjustments” of study results to correct known biases; and (d) developing synthesis frameworks and models that will minimize the impact of hidden biases.

Copyright
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1. H. J. M. Barnett , D. Sackett , D. W. Taylor , Are the results of the Extracranial Intracranial Bypass Trial generalizable? New England Journal of Medicine, 1987, 316, 820–24.

2. D. P. Byar Why data bases should not replace randomized clinical trials. Biometrics, 1980, 36, 337–42.

3. D. P. Byar , D. A. Schoenfeld , S. B. Green , Design considerations for AIDS trials. New England Journal of Medicine, 1990, 323, 1343–48.

4. R. M. Calif , D. B. Pryor , & J. C. Greenfield Beyond randomized clinical trials: applying clinical experience in the treatment of patients with coronary artery disease. Circulation, 1986, 74, 1191–94.

5. T. C. Chalmers , H. Smith Jr., B. Blackburn , A Method for assessing the quality of a randomized control trial. Controlled Clinical Trials, 1981, 2, 3149.

14. P. M. Ellwood A technology of patient experience. New England Journal of Medicine, 1988, 318, 1549–56.

15. K. Fischerman , & H. T. Mouridsen Danish Breast Cancer Cooperative Group (DBCG): Structure and results of the organization. Acta Oncologica, 1988, 27, 593–96.

21. H. N. Himel , A. Liberati , R. Gelber , & T. C. Chalmers Adjuvant chemotherapy for breast cancer: A pooled estimate based on published randomized control trials. Journal of the American Medical Association, 1986, 256, 1148–59.

22. M. A. Hlatky Using databases to evaluate therapy. Statistics in Medicine, 1991, 10, 647–52.

24. G. B. Jackson Methods for integrative reviews. Review of Educational Research, 1980, 50, 438–60. (Reprinted in R. J. Light (ed.), Evaluation studies review annual, vol. 8. Beverly Hills, CA: Sage, 1983.)

26. H. Krakauer , & R. C. Bailey Epidemiological oversight of the medical care provided to Medicare beneficiaries. Statistics in Medicine, 1991, 10, 521–40.

30. T. A. Louis , H. V. Fineberg , & F. Mosteller Findings for public health from metaanalyses. Annual Review of Public Health, 1985, 6, 120.

31. C. McDonald , & H. Siu The analysis of humongous databases: Problems and promises. Statistics in Medicine, 1991, 10, 511–18.

32. R. Moffitt Program evaluation with nonexperimental data. Evaluation Review, 1991, 15(3), 291314.

34. R. Peto Why do we need systematic overviews of randomized trials? Statistics in Medicine, 1987, 6, 233–40.

36. D. B. Pryor , R. M. Califf , F. E. Harrell Jr., Clinical data bases: Accomplishments and unrealized potential. Medical Care, 1985, 23(5), 623–47.

37. N. Roos , J. Wennberg , D. Malenka , Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. New England Journal of Medicine, 1989, 320, 1120–24.

38. W. L. Roper , W. Winkenwerder , G. M. Hackbarth , & H. Krakauer Effectiveness in health care: An initiative to evaluate and improve medical practice. New England Journal of Medicine, 1988, 319, 11971202.

40. D. B. Rubin Practical implications of modes of statistical inference for causal effects and the critical role of the assignment mechanism. Biometrics, 1991, 47(4), 1213–34.

42. D. B. Rubin Estimating causal effects of treatments in randomized and nonrandomized studies. Journal of Educational Psychology, 1974, 66, 688701.

44. K. M. Taylor , R. G. Margolese , & C. L. Soskoline Physicians reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. New England Journal of Medicine, 1984, 310, 1363–67.

48. J. E. Wennberg , J. L. Freeman , R. M. Shelton , & T. A. Bubolz Hospital use and mortality among medicare beneficiaries in Boston and New Haven. New England Journal of Medicine, 1989, 321, 1168–73.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 15 *
Loading metrics...

Abstract views

Total abstract views: 70 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 28th March 2017. This data will be updated every 24 hours.